Correlation Between Vincerx Pharma and TG Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vincerx Pharma and TG Therapeutics, you can compare the effects of market volatilities on Vincerx Pharma and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma and TG Therapeutics.
Diversification Opportunities for Vincerx Pharma and TG Therapeutics
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vincerx and TGTX is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and Vincerx Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of Vincerx Pharma i.e., Vincerx Pharma and TG Therapeutics go up and down completely randomly.
Pair Corralation between Vincerx Pharma and TG Therapeutics
Given the investment horizon of 90 days Vincerx Pharma is expected to under-perform the TG Therapeutics. In addition to that, Vincerx Pharma is 2.51 times more volatile than TG Therapeutics. It trades about -0.18 of its total potential returns per unit of risk. TG Therapeutics is currently generating about 0.11 per unit of volatility. If you would invest 2,261 in TG Therapeutics on November 2, 2024 and sell it today you would earn a total of 1,075 from holding TG Therapeutics or generate 47.55% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Vincerx Pharma vs. TG Therapeutics
Performance |
Timeline |
Vincerx Pharma |
TG Therapeutics |
Vincerx Pharma and TG Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vincerx Pharma and TG Therapeutics
The main advantage of trading using opposite Vincerx Pharma and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.Vincerx Pharma vs. Spero Therapeutics | Vincerx Pharma vs. Bolt Biotherapeutics | Vincerx Pharma vs. Coherus BioSciences | Vincerx Pharma vs. Applied Therapeutics |
TG Therapeutics vs. Madrigal Pharmaceuticals | TG Therapeutics vs. Terns Pharmaceuticals | TG Therapeutics vs. Hepion Pharmaceuticals | TG Therapeutics vs. Exelixis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Stocks Directory Find actively traded stocks across global markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |